Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
about
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsStructural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding proteinStructural Analysis of WbpE from Pseudomonas aeruginosa PAO1: A Nucleotide Sugar Aminotransferase Involved in O-Antigen Assembly,Structure Guided Development of Novel Thymidine Mimetics Targeting Pseudomonas aeruginosa Thymidylate Kinase: From Hit to Lead GenerationUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and deathThe glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosaNew amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesChemical probes for competitive profiling of the quorum sensing signal synthase PqsD of Pseudomonas aeruginosaSolution structure and properties of AlgH from Pseudomonas aeruginosa.Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma.The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract.Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis.SOS involvement in stress-inducible biofilm formation.Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.Burn Patients Infected With Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa: Multidrug-Resistant Strains.Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing.Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa.Investigation of pulmonary infection pathogens in neurological intensive care unit.Cytotoxicity and inflammatory potential of two Pseudomonas mosselii strains isolated from clinical samples of hospitalized patients.Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in diseaseIdentification of five structurally unrelated quorum-sensing inhibitors of Pseudomonas aeruginosa from a natural-derivative database.Autophagy enhances bacterial clearance during P. aeruginosa lung infection.Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: Towards characterizing host-pathogen interactions in gut-derived sepsisQuantitative impact of neutrophils on bacterial clearance in a murine pneumonia modelComposition and Predicted Metabolic Capacity of Upper and Lower Airway Microbiota of Healthy Dogs in Relation to the Fecal MicrobiotaPseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protectionTreatment of Pseudomonas aeruginosa infection in critically ill patients.Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.Epidemics of drug-resistant bacterial infections observed in infectious disease surveillance in Japan, 2001-2005.Successful Treatment of Multi-Drug Resistant Pseudomonas aeruginosa Bacteremia with the Recommended Renally Adjusted Ceftolozane/Tazobactam Regimen.Antibiotic Resistance Patterns of Escherichia coli Isolates from Hospitals in Kumasi, Ghana.Emergence of NDM - 1 in the Clinical Isolates of Pseudomonas aeruginosa in India.A proposal for augmenting biological model construction with a semi-intelligent computational modeling assistantBroad-spectrum antimicrobial epiphytic and endophytic fungi from marine organisms: isolation, bioassay and taxonomyDo Bacterial "Virulence Factors" Always Increase Virulence? A Meta-Analysis of Pyoverdine Production in Pseudomonas aeruginosa As a Test Case
P2860
Q24673399-4F664549-357D-4EAA-ACEC-1AB3013C623EQ26823401-0A999F15-DBDA-4222-AF26-9BF4D122BA8CQ27653885-978628BB-179D-47C5-8E9E-07C52B242D45Q27663161-0D6B39D3-BB5A-4A46-8E45-4A55197398DCQ27676722-A4322862-682A-48CB-AA55-338EC19D823AQ28265803-0F3FF7A9-E835-49EE-A275-22A819FE490BQ28289283-A44A0C25-8545-4BE7-BEE8-4DD4F2FD8295Q28492495-EB41EA5B-59C6-4CD2-B17E-7170AC1565F0Q28654498-3DE927CA-9E86-4501-95C9-62A7FEABCFBDQ28817226-0FF8E8BE-00EF-4EDC-989E-D9B556C8E338Q30373528-0C1104F1-4C88-459E-9DBA-E8A1E8F83080Q33455715-47D8C9E0-E7A2-4958-BF98-D7A6400D3A55Q33457725-A87EE030-D9AB-4394-ACA5-906B300D40AEQ33497911-ED5D996E-F0B7-4265-9E54-ADD30F61C92FQ33625735-CB51BB93-FECC-453F-9962-DAA66E8F0F70Q33876563-B0C38505-5E4D-4D94-ACB6-485A71A96E4FQ34071886-8178551F-E861-4F32-8D5A-6720A6B92615Q34095684-94851E2A-BEF5-4079-8C8C-5259580EB20CQ34165319-128C24AB-FC4E-498B-8FDA-0AE41C499CF8Q34252814-1E169A75-EC2A-4448-85E6-721BD09009B7Q34290150-1E2AB7E0-C273-4036-95E0-E74A3FBBD81AQ34574162-FE936177-C399-4C86-805B-1D88FD12B10FQ34746835-F82CF000-8217-475C-B1B5-36D3332CA823Q34824481-6A83B661-0FC2-4B75-862D-B3074E18A117Q34977749-F9F5BF04-8B89-49D7-9CCA-4D86A57028FBQ34981436-7D84B5C8-4853-40E4-BA54-D4D2490E9149Q35249826-C20E2C84-082D-4187-823C-7A34BE4E2BA5Q35270290-6142322B-B9B8-46F9-B92B-E80131DB836EQ36005291-4366079B-83E0-4A42-A084-8478AFF1910FQ36013525-79DC5E97-8E60-4EF0-8328-281C3791934AQ36539114-196DE2E0-6203-4077-9C04-BECD220B9755Q36607415-9946CC92-ED62-4813-874D-F2C393F7CC89Q36667202-90A1C893-7BA1-468B-8A77-49FF52813ADFQ36733355-E568D083-139B-4DD0-84B8-3F1A9B23B9D4Q36740013-583BFB23-CEB5-4093-B3A6-AE52F9B05F24Q36900168-A55F9B17-C3E5-4944-9C44-0BE5031FF9EBQ37111302-D276E8E1-7947-4213-8AD8-E47525DA07D6Q37124394-5415BA1C-CB96-4CAB-AC5C-012A4575BEC1Q37253565-69C88DBB-3911-46C3-8974-89EF735C13A2Q37492055-93B22E85-C19B-474C-BFC6-4546192C0AAD
P2860
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Nosocomial infections due to m ...... miology and treatment options.
@ast
Nosocomial infections due to m ...... miology and treatment options.
@en
type
label
Nosocomial infections due to m ...... miology and treatment options.
@ast
Nosocomial infections due to m ...... miology and treatment options.
@en
prefLabel
Nosocomial infections due to m ...... miology and treatment options.
@ast
Nosocomial infections due to m ...... miology and treatment options.
@en
P2093
P2860
P1433
P1476
Nosocomial infections due to m ...... miology and treatment options.
@en
P2093
Douglas N Fish
Marilee D Obritsch
Robert MacLaren
P2860
P304
P356
10.1592/PHCO.2005.25.10.1353
P407
P577
2005-10-01T00:00:00Z